@article{ref1,
title="Advice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 1. On medical care and treatment of injuries from blister and nerve agents",
journal="Toxicology",
year="2019",
author="Timperley, Christopher M. and Forman, Jonathan E. and Abdollahi, Mohammad and Al-Amri, Abdullah Saeed and Baulig, Augustin and Benachour, Djafer and Borrett, Veronica and Cariño, Flerida A. and Geist, Michael and Gonzalez, David and Kane, William and Kovarik, Zrinka and Martínez-Álvarez, Roberto and Fusaro Mourão, Nicia Maria and Neffe, Slawomir and Raza, Syed K. and Rubaylo, Valentin and Suárez, Alejandra Graciela and Takeuchi, Koji and Tang, Cheng and Trifirò, Ferruccio and van Straten, Francois Mauritz and Vanninen, Paula S. and Vucinić, Slavica and Zaitsev, Volodymyr and Zafar-Uz-Zaman, Muhammad and Zina, Mongia Saïd and Holen, Stian",
volume="415",
number="",
pages="56-69",
abstract="The Scientific Advisory Board (SAB) of the Organisation for the Prohibition of Chemical Weapons (OPCW) has provided advice on assistance and protection in relation to the Chemical Weapons Convention. In this, the first of three sequential papers describing the SAB's work on this topic, we describe advice given in response to questions from the OPCW Director-General in 2013 and 2014 on the status of available medical countermeasures and treatments to blister and nerve agents. This paper provides the evidence base for this advice which recommended to the OPCW pretreatments, emergency care, and long-term treatments that were available at the time of the request for both classes of chemical warfare agent (CWA). It includes a bibliography of over 200 scientific references, which can be used as a platform for watching future medical countermeasure developments. The information provided in this paper should serve as a valuable reference for medical professionals and emergency responders who may have no knowledge of the symptoms and treatment options of exposure to CWAs.<br><br>Copyright © 2019. Published by Elsevier B.V.<p /> <p>Language: en</p>",
language="en",
issn="0300-483X",
doi="10.1016/j.tox.2019.01.004",
url="http://dx.doi.org/10.1016/j.tox.2019.01.004"
}